カテゴリー： Market Monitor Global, 世界, 医療/バイオ

凍結乾燥口腔内崩壊製剤のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品

◆英語タイトル：Freeze-Dried Orally Disintegrating Preparations Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14330）

◆商品コード：MMG23DC14330
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

凍結乾燥口腔内崩壊製剤（Orally Disintegrating Preparations）は、口腔内で容易に崩壊し、溶解することを目的とした製剤であり、患者が水を必要とせずに服用できる特性を持っています。この製剤形態は特に、高齢者や嚥下困難な患者、小児などに対して有用であり、服用の便利さと服用 Compliance（遵守）を向上させることが期待されています。

凍結乾燥口腔内崩壊製剤は、一般的に凍結乾燥法を用いて製造されます。凍結乾燥とは、液体の水分を氷にし、さらにその氷を真空中で昇華させて水分を取り除くプロセスを指します。この過程により、薬剤の活性成分が保持されるとともに、長期間の保存が可能となります。製剤は軽量で、通常は口の中で簡単に崩壊し、迅速に溶解します。

この製剤の特徴としては、まず挙げられるのがその使用の簡便さです。従来の経口投与のように水を必要とせず、服用時の心理的抵抗も少ないため、子どもや高齢者にとっては特に大きな利点となります。また、口腔内で迅速に溶解するため、迅速な薬効発現が期待できる点も挙げられます。

凍結乾燥口腔内崩壊製剤は、様々な種類があります。主に、単一成分製剤と複合製剤に分類できます。単一成分製剤は、特定の薬剤を含むもので、主にその薬剤の効用を直接的に患者に提供します。一方、複合製剤は、複数の薬剤を含み、異なる作用機序や相互作用を活かして、より効果的な治療を提供します。また、フレーバーや甘味料を追加することで、より飲みやすくする工夫もなされています。

用途としては、主に神経系の疾患に使用されることが多いです。たとえば、抗うつ剤、抗精神病薬、鎮痛薬などは、迅速な効果発現が求められる場合が多いため、凍結乾燥口腔内崩壊製剤としての特性が活かされます。また、風邪やインフルエンザの症状を和らげるための製剤や、糖尿病治療薬など、広範囲にわたる用途が考えられます。

さらに、関連技術についても触れておく必要があります。製剤の開発には、薬剤の選定とその配合比、製造過程の管理、さらには崩壊速度の最適化などが含まれます。また、製剤の安定性を向上させるための技術も重要であり、例えば、湿気に対する感受性を考慮して、適切な包装材を選定することや、保存条件を工夫することが求められます。

最近では、ナノテクノロジーやマイクロエンカプセレーション技術の活用が進んでおり、より高精度な製剤設計が可能になっています。これにより、製剤の放出特性を制御することができ、治療効果の最大化が図られています。また、患者ごとのニーズに応じたオーダーメイドの製剤開発も期待されています。

凍結乾燥口腔内崩壊製剤は、今後ますますその重要性が増すと考えられます。特に、医療の現場では、患者のQOL（生活の質）を向上させる取り組みが求められており、この製剤形態はそのニーズに応える優れた選択肢となります。患者への負担を軽減し、治療の効果を最大化するためのさらなる研究と開発が進められていくことが期待されます。

当調査レポートは次の情報を含め、世界の凍結乾燥口腔内崩壊製剤市場規模と予測を収録しています。・世界の凍結乾燥口腔内崩壊製剤市場：売上、2018年-2023年、2024年-2029年
・世界の凍結乾燥口腔内崩壊製剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の凍結乾燥口腔内崩壊製剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療用医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

凍結乾燥口腔内崩壊製剤のグローバル主要企業は、Wyeth、 Eli Lilly and Company、 Takeda Pharmaceutical、 Astellas Pharma、 Neos Therapeutics、 Janssen、 Catalent Pharma Solutions、 Salix Pharmaceuticals、 Elan、 APOTEX、 Beijing Sunho Pharmaceutical、 Quantum Hi-tech(China) Pharmaceutical、 KV Pharmaceutical、 Biovail Corporation、 SPl Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、凍結乾燥口腔内崩壊製剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の凍結乾燥口腔内崩壊製剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の凍結乾燥口腔内崩壊製剤市場：タイプ別市場シェア、2022年
・医療用医薬品、一般用医薬品

世界の凍結乾燥口腔内崩壊製剤市場：用途別、2018年-2023年、2024年-2029年
世界の凍結乾燥口腔内崩壊製剤市場：用途別市場シェア、2022年
・医療、健康、その他

世界の凍結乾燥口腔内崩壊製剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の凍結乾燥口腔内崩壊製剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における凍結乾燥口腔内崩壊製剤のグローバル売上、2018年-2023年
・主要企業における凍結乾燥口腔内崩壊製剤のグローバル売上シェア、2022年
・主要企業における凍結乾燥口腔内崩壊製剤のグローバル販売量、2018年-2023年
・主要企業における凍結乾燥口腔内崩壊製剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Wyeth、 Eli Lilly and Company、 Takeda Pharmaceutical、 Astellas Pharma、 Neos Therapeutics、 Janssen、 Catalent Pharma Solutions、 Salix Pharmaceuticals、 Elan、 APOTEX、 Beijing Sunho Pharmaceutical、 Quantum Hi-tech(China) Pharmaceutical、 KV Pharmaceutical、 Biovail Corporation、 SPl Pharma

*************************************************************

・調査・分析レポートの概要
凍結乾燥口腔内崩壊製剤市場の定義
市場セグメント
世界の凍結乾燥口腔内崩壊製剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の凍結乾燥口腔内崩壊製剤市場規模
世界の凍結乾燥口腔内崩壊製剤市場規模：2022年 VS 2029年
世界の凍結乾燥口腔内崩壊製剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの凍結乾燥口腔内崩壊製剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の凍結乾燥口腔内崩壊製剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：医療用医薬品、一般用医薬品
凍結乾燥口腔内崩壊製剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医療、健康、その他
凍結乾燥口腔内崩壊製剤の用途別グローバル売上・予測

・地域別市場分析
地域別凍結乾燥口腔内崩壊製剤市場規模 2022年と2029年
地域別凍結乾燥口腔内崩壊製剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Wyeth、 Eli Lilly and Company、 Takeda Pharmaceutical、 Astellas Pharma、 Neos Therapeutics、 Janssen、 Catalent Pharma Solutions、 Salix Pharmaceuticals、 Elan、 APOTEX、 Beijing Sunho Pharmaceutical、 Quantum Hi-tech(China) Pharmaceutical、 KV Pharmaceutical、 Biovail Corporation、 SPl Pharma
...

This research report provides a comprehensive analysis of the Freeze-Dried Orally Disintegrating Preparations market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Freeze-Dried Orally Disintegrating Preparations market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Freeze-Dried Orally Disintegrating Preparations, challenges faced by the industry, and potential opportunities for market players.
The global Freeze-Dried Orally Disintegrating Preparations market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Freeze-Dried Orally Disintegrating Preparations market presents opportunities for various stakeholders, including Medical Field, Health Field. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Freeze-Dried Orally Disintegrating Preparations market. Additionally, the growing consumer demand present avenues for market expansion.
The global Freeze-Dried Orally Disintegrating Preparations market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Freeze-Dried Orally Disintegrating Preparations market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Freeze-Dried Orally Disintegrating Preparations market.
Market Overview: The report provides a comprehensive overview of the Freeze-Dried Orally Disintegrating Preparations market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Prescription Drugs, Non-Prescription Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Freeze-Dried Orally Disintegrating Preparations market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Freeze-Dried Orally Disintegrating Preparations market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Freeze-Dried Orally Disintegrating Preparations market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Freeze-Dried Orally Disintegrating Preparations market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Freeze-Dried Orally Disintegrating Preparations market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Freeze-Dried Orally Disintegrating Preparations market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Freeze-Dried Orally Disintegrating Preparations, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Freeze-Dried Orally Disintegrating Preparations market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Freeze-Dried Orally Disintegrating Preparations market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Prescription Drugs
Non-Prescription Drugs
Market segment by Application
Medical Field
Health Field
Others
Global Freeze-Dried Orally Disintegrating Preparations Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Wyeth
Eli Lilly and Company
Takeda Pharmaceutical
Astellas Pharma
Neos Therapeutics
Janssen
Catalent Pharma Solutions
Salix Pharmaceuticals
Elan
APOTEX
Beijing Sunho Pharmaceutical
Quantum Hi-tech(China) Pharmaceutical
KV Pharmaceutical
Biovail Corporation
SPl Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Freeze-Dried Orally Disintegrating Preparations, market overview.
Chapter 2: Global Freeze-Dried Orally Disintegrating Preparations market size in revenue.
Chapter 3: Detailed analysis of Freeze-Dried Orally Disintegrating Preparations company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Freeze-Dried Orally Disintegrating Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Freeze-Dried Orally Disintegrating Preparations Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Freeze-Dried Orally Disintegrating Preparations Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Freeze-Dried Orally Disintegrating Preparations Overall Market Size
2.1 Global Freeze-Dried Orally Disintegrating Preparations Market Size: 2022 VS 2029
2.2 Global Freeze-Dried Orally Disintegrating Preparations Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Freeze-Dried Orally Disintegrating Preparations Players in Global Market
3.2 Top Global Freeze-Dried Orally Disintegrating Preparations Companies Ranked by Revenue
3.3 Global Freeze-Dried Orally Disintegrating Preparations Revenue by Companies
3.4 Top 3 and Top 5 Freeze-Dried Orally Disintegrating Preparations Companies in Global Market, by Revenue in 2022
3.5 Global Companies Freeze-Dried Orally Disintegrating Preparations Product Type
3.6 Tier 1, Tier 2 and Tier 3 Freeze-Dried Orally Disintegrating Preparations Players in Global Market
3.6.1 List of Global Tier 1 Freeze-Dried Orally Disintegrating Preparations Companies
3.6.2 List of Global Tier 2 and Tier 3 Freeze-Dried Orally Disintegrating Preparations Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Freeze-Dried Orally Disintegrating Preparations Market Size Markets, 2022 & 2029
4.1.2 Prescription Drugs
4.1.3 Non-Prescription Drugs
4.2 By Type – Global Freeze-Dried Orally Disintegrating Preparations Revenue & Forecasts
4.2.1 By Type – Global Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2023
4.2.2 By Type – Global Freeze-Dried Orally Disintegrating Preparations Revenue, 2024-2029
4.2.3 By Type – Global Freeze-Dried Orally Disintegrating Preparations Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Freeze-Dried Orally Disintegrating Preparations Market Size, 2022 & 2029
5.1.2 Medical Field
5.1.3 Health Field
5.1.4 Others
5.2 By Application – Global Freeze-Dried Orally Disintegrating Preparations Revenue & Forecasts
5.2.1 By Application – Global Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2023
5.2.2 By Application – Global Freeze-Dried Orally Disintegrating Preparations Revenue, 2024-2029
5.2.3 By Application – Global Freeze-Dried Orally Disintegrating Preparations Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Freeze-Dried Orally Disintegrating Preparations Market Size, 2022 & 2029
6.2 By Region – Global Freeze-Dried Orally Disintegrating Preparations Revenue & Forecasts
6.2.1 By Region – Global Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2023
6.2.2 By Region – Global Freeze-Dried Orally Disintegrating Preparations Revenue, 2024-2029
6.2.3 By Region – Global Freeze-Dried Orally Disintegrating Preparations Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2029
6.3.2 US Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.3.3 Canada Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.3.4 Mexico Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2029
6.4.2 Germany Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4.3 France Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4.4 U.K. Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4.5 Italy Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4.6 Russia Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4.7 Nordic Countries Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.4.8 Benelux Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2029
6.5.2 China Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.5.3 Japan Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.5.4 South Korea Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.5.5 Southeast Asia Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.5.6 India Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2029
6.6.2 Brazil Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.6.3 Argentina Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Freeze-Dried Orally Disintegrating Preparations Revenue, 2018-2029
6.7.2 Turkey Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.7.3 Israel Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.7.4 Saudi Arabia Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
6.7.5 UAE Freeze-Dried Orally Disintegrating Preparations Market Size, 2018-2029
7 Freeze-Dried Orally Disintegrating Preparations Companies Profiles
7.1 Wyeth
7.1.1 Wyeth Company Summary
7.1.2 Wyeth Business Overview
7.1.3 Wyeth Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.1.4 Wyeth Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.1.5 Wyeth Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.2.4 Eli Lilly and Company Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly and Company Key News & Latest Developments
7.3 Takeda Pharmaceutical
7.3.1 Takeda Pharmaceutical Company Summary
7.3.2 Takeda Pharmaceutical Business Overview
7.3.3 Takeda Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.3.4 Takeda Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.3.5 Takeda Pharmaceutical Key News & Latest Developments
7.4 Astellas Pharma
7.4.1 Astellas Pharma Company Summary
7.4.2 Astellas Pharma Business Overview
7.4.3 Astellas Pharma Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.4.4 Astellas Pharma Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.4.5 Astellas Pharma Key News & Latest Developments
7.5 Neos Therapeutics
7.5.1 Neos Therapeutics Company Summary
7.5.2 Neos Therapeutics Business Overview
7.5.3 Neos Therapeutics Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.5.4 Neos Therapeutics Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.5.5 Neos Therapeutics Key News & Latest Developments
7.6 Janssen
7.6.1 Janssen Company Summary
7.6.2 Janssen Business Overview
7.6.3 Janssen Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.6.4 Janssen Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.6.5 Janssen Key News & Latest Developments
7.7 Catalent Pharma Solutions
7.7.1 Catalent Pharma Solutions Company Summary
7.7.2 Catalent Pharma Solutions Business Overview
7.7.3 Catalent Pharma Solutions Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.7.4 Catalent Pharma Solutions Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.7.5 Catalent Pharma Solutions Key News & Latest Developments
7.8 Salix Pharmaceuticals
7.8.1 Salix Pharmaceuticals Company Summary
7.8.2 Salix Pharmaceuticals Business Overview
7.8.3 Salix Pharmaceuticals Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.8.4 Salix Pharmaceuticals Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.8.5 Salix Pharmaceuticals Key News & Latest Developments
7.9 Elan
7.9.1 Elan Company Summary
7.9.2 Elan Business Overview
7.9.3 Elan Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.9.4 Elan Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.9.5 Elan Key News & Latest Developments
7.10 APOTEX
7.10.1 APOTEX Company Summary
7.10.2 APOTEX Business Overview
7.10.3 APOTEX Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.10.4 APOTEX Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.10.5 APOTEX Key News & Latest Developments
7.11 Beijing Sunho Pharmaceutical
7.11.1 Beijing Sunho Pharmaceutical Company Summary
7.11.2 Beijing Sunho Pharmaceutical Business Overview
7.11.3 Beijing Sunho Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.11.4 Beijing Sunho Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.11.5 Beijing Sunho Pharmaceutical Key News & Latest Developments
7.12 Quantum Hi-tech(China) Pharmaceutical
7.12.1 Quantum Hi-tech(China) Pharmaceutical Company Summary
7.12.2 Quantum Hi-tech(China) Pharmaceutical Business Overview
7.12.3 Quantum Hi-tech(China) Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.12.4 Quantum Hi-tech(China) Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.12.5 Quantum Hi-tech(China) Pharmaceutical Key News & Latest Developments
7.13 KV Pharmaceutical
7.13.1 KV Pharmaceutical Company Summary
7.13.2 KV Pharmaceutical Business Overview
7.13.3 KV Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.13.4 KV Pharmaceutical Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.13.5 KV Pharmaceutical Key News & Latest Developments
7.14 Biovail Corporation
7.14.1 Biovail Corporation Company Summary
7.14.2 Biovail Corporation Business Overview
7.14.3 Biovail Corporation Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.14.4 Biovail Corporation Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.14.5 Biovail Corporation Key News & Latest Developments
7.15 SPl Pharma
7.15.1 SPl Pharma Company Summary
7.15.2 SPl Pharma Business Overview
7.15.3 SPl Pharma Freeze-Dried Orally Disintegrating Preparations Major Product Offerings
7.15.4 SPl Pharma Freeze-Dried Orally Disintegrating Preparations Revenue in Global Market (2018-2023)
7.15.5 SPl Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 凍結乾燥口腔内崩壊製剤のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品(Freeze-Dried Orally Disintegrating Preparations Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

凍結乾燥口腔内崩壊製剤のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp